CBOE · US Equities - Factor & Thematic · USA
The companies inside OMFS trade 9% below what we estimate they are worth. We could give a verdict on 95% of the fund's weight: 1107 holdings as reported to the SEC at 31 May 2026.
Where the money is: 25% in companies in the buy zone, 26% about fairly valued, 43% overvalued, 5% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 0.39% a year: on $10,000 held flat that is $390 over 10 years and $780 over 20.